In type 2 diabetes (T2D), representing approximately 90% of the diabetes cases, patients present a loss of β-cell function and/or a resistance of the target tissues (liver, muscle and adipose tissue) to insulin action (9). This evidence concerns the gene INS and diabetes mellitus.